During newly come years, a sizeabl...
During newly come years, a sizeable number of put drugs intos have been withdrawn from the market because of their harmful side general intents (1-7) Reasons most commonly cited were adverse events of the hepatic, hematologic, and cardiovascular plans In three high profile withdrawals in 2000 cisapride (Propulsid), a chronic heartburn physic approved in 1993; troglitazone (Rezulin), a diabetes remedy approved in 1997; and Lotronex a treatment for irritable bowel syndrome were shakeed from the market because of serious side tenors In each case, new knowledge about its side drifts altered the ...
|